OTCWagon Issues Update on Therma Bright, Inc. (THRM)
Extremely Undervalued Company - Therma Bright, Inc. (THRM) - Amazing Opportunity
They are focused on servicing the $21 billion cosmeceutical industry. Therma Bright Inc. (THRM) holds patents pending and the trademarks for Therozap™ and the trademark InterceptCS™
Therma Bright Inc. (THRM) has spent a significant investment in intellectual property and research and development for its InterceptCS™-
Therma's current product lines address cold sore treatment and prevention, and the treatment of pain, itch and inflammation related to mosquito, bee, spider, mite, and jellyfish bites or stings.
Therma Bright is in the research and development stage to develop a novel device for relief of pain associated with back, knee or other joint pain.
OTCWagon is excited to watch as the word gets out on Therma Bright, Inc. (THRM). In our opinion, once word gets out on Therma Bright, Inc. (THRM) the sky is the limit! The ONLY question left is: WHAT ARE YOU WAITING FOR?
JOHN - IT STAFF